Home › Funds › ORBIMED ADVISORS LLC › WST
ORBIMED ADVISORS LLC position in WST
WEST PHARMACEUTICAL SVSC INC · Health Care
ORBIMED ADVISORS LLC reported holding 70,600 shares of WST (WEST PHARMACEUTICAL SVSC INC) in its Q2 2026 13F filing — a position valued at US$25.3M, representing 0.51% of its reported portfolio and ranking #50 among its reported holdings. ORBIMED ADVISORS LLC first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How ORBIMED ADVISORS LLC's WST position evolved
ORBIMED ADVISORS LLC first disclosed a stake in WST in Q2 2026 at 70,600 shares (US$25.3M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 70.60K | $25.35M | New |
About WST and 13F data
WST (WEST PHARMACEUTICAL SVSC INC) is a Health Care company. 35 other funds we track also report a position in WST — the largest reported positions include Artisan Partners Limited Partnership (US$865.8M), GENERATION INVESTMENT MANAGEMENT LLP (US$728.2M), BROWN ADVISORY INC (US$386.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding WST
- Artisan Partners Limited Partnership 2.41M sh · $865.83M · Q2 2026
- GENERATION INVESTMENT MANAGEMENT LLP 2.03M sh · $728.17M · Q2 2026
- BROWN ADVISORY INC 1.08M sh · $386.04M · Q2 2026
- Longview Partners (Guernsey) LTD 1.03M sh · $371.14M · Q2 2026
- KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 760.62K sh · $273.06M · Q2 2026
- ProShare Advisors LLC 598.02K sh · $214.69M · Q2 2026
- Findlay Park Partners LLP 596.65K sh · $214.20M · Q2 2026
- Epoch Investment Partners, Inc. 562.56K sh · $201.96M · Q2 2026
- JACOBS LEVY EQUITY MANAGEMENT, INC 507.79K sh · $182.30M · Q2 2026
More on ORBIMED ADVISORS LLC
FAQ
How long has ORBIMED ADVISORS LLC held WST?
ORBIMED ADVISORS LLC has disclosed WST holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is ORBIMED ADVISORS LLC's current position in WST?
As of Q2 2026, ORBIMED ADVISORS LLC holds 70.60K shares of WST (WEST PHARMACEUTICAL SVSC INC), valued at $25.35M, representing 0.51% of its reported portfolio and ranking #50.
Has ORBIMED ADVISORS LLC been buying or selling WST?
In the latest 13F filing (Q2 2026), ORBIMED ADVISORS LLC newly opened its position in WST.
Which other funds hold WST?
Other major institutional holders of WST include Artisan Partners Limited Partnership, GENERATION INVESTMENT MANAGEMENT LLP, BROWN ADVISORY INC, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.